NYSEARCA:FBT First Trust NYSE Arca Biotechnology Index Fund (FBT) Price, Holdings, & News $177.65 +1.67 (+0.95%) As of 03:42 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartHoldingsOwnershipRatings About First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get FBT alerts:Sign Up Key Stats Today's Range$175.72▼$177.9950-Day Range$164.02▼$182.1952-Week Range$140.36▼$183.60Volume16,165 shsAverage Volume29,267 shsMarket Capitalization$1.34 billionAssets Under Management$1.17 billionDividend Yield0.00%Net Expense Ratio0.56%Aggregate RatingModerate Buy ETF OverviewThe First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund that is based on the NYSE Arca Biotechnology index. The fund tracks an equal-weighted index of US biotechnology stocks. FBT was launched on Jun 19, 2006 and is managed by First Trust.Read More… First Trust NYSE Arca Biotechnology Index Fund ExpensesTypeFBTHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.40%0.57%0.56%0.51%0.52%Other Expenses0.16%0.30%0.50%0.57%0.53%Total Expense0.56%0.70%0.72%0.73%0.71%Fee Waiver0.00%-0.45%-0.50%-0.66%-0.56%Net Expense0.56%0.61%0.62%0.58%0.60% Receive FBT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for First Trust NYSE Arca Biotechnology Index Fund and its competitors with MarketBeat's FREE daily newsletter. Email Address FBT ETF News HeadlinesFirst Trust Announces Completion of MergersMay 6, 2024 | tmcnet.comFirst Trust NYSE Arca Biotechnology Index Fund (FBT)March 31, 2024 | finance.yahoo.comBetter than Bitcoin – and potentially more profitableThe world is obsessed with Bitcoin again... And for a good reason: It just soared beyond $100,000. Bitcoin Skimming allows you to “skim” cash into your account thanks to 2025’s surging Bitcoin market.February 19, 2025 | Brownstone Research (Ad)Closing Bell: First Trust NYSE Arca Biotechnology ETF up on Friday (FBT)January 6, 2024 | theglobeandmail.comClosing Bell: First Trust NYSE Arca Biotechnology ETF flat on Friday (FBT)January 6, 2024 | theglobeandmail.comFirst Trust Dynamic Europe Equity Income Fund Declares its Monthly Common Share Distribution of $0.07 Per Share for NovemberOctober 23, 2023 | benzinga.comSee More Headlines FBT ETF - Frequently Asked Questions How have FBT shares performed this year? First Trust NYSE Arca Biotechnology Index Fund's stock was trading at $166.21 at the beginning of 2025. Since then, FBT stock has increased by 7.0% and is now trading at $177.82. View the best growth stocks for 2025 here. Who are First Trust NYSE Arca Biotechnology Index Fund's major shareholders? First Trust NYSE Arca Biotechnology Index Fund's top institutional investors include Bank of America Corp DE (2.89%), Wells Fargo & Company MN (2.52%), LPL Financial LLC (2.48%) and Raymond James Financial Inc. (2.21%). How do I buy shares of First Trust NYSE Arca Biotechnology Index Fund? Shares of FBT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of First Trust NYSE Arca Biotechnology Index Fund own? Based on aggregate information from My MarketBeat watchlists, some other companies that First Trust NYSE Arca Biotechnology Index Fund investors own include DiamondRock Hospitality (DRH), iShares Micro-Cap ETF (IWC), The RMR Group (RMR), Waste Connections (WCN), AUO (AUOTY), American Water Works (AWK) and Triple Flag Precious Metals (TFPM). Fund Details IssuerFirst Trust Fund NameFirst Trust NYSE Arca Biotechnology Index Fund Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:FBT Inception Date6/19/2006 Fund ManagerDaniel J. Lindquist, Jon Erickson David McGarel, RogerTestin, Stan Ueland, Chris Peterson, Erik Russo WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkNYSE Arca Biotechnology Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Number of Holdings31 Fund Statistics Assets Under Management$1.18 billion Average Daily Volume$28,943.70 Discount/Premium-0.17% Administrator, Advisor and Custodian AdministratorThe Bank of New York Mellon Corporation AdvisorFirst Trust Advisors L.P. CustodianThe Bank of New York Mellon Corporation DistributorFirst Trust Portfolios L.P. Transfer AgentThe Bank of New York Mellon Corporation TrusteeN/A Lead Market MakerRBC Capital Markets Options OptionableN/A Short Interest12,100 shs Miscellaneous Outstanding Shares7,550,000Beta0.86 Creation Unit50,000 Creation Fee$500.00 Reduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free Report Top 10 FBT HoldingsCorcept Therapeutics (NASDAQ:CORT)Holding Weight: 4.53%Intra-Cellular Therapies (NASDAQ:ITCI)Holding Weight: 4.46%Beigene (NASDAQ:ONC)Holding Weight: 4.15%Alkermes (NASDAQ:ALKS)Holding Weight: 3.78%Alnylam Pharmaceuticals (NASDAQ:ALNY)Holding Weight: 3.75%Amgen (NASDAQ:AMGN)Holding Weight: 3.75%Vertex Pharmaceuticals (NASDAQ:VRTX)Holding Weight: 3.69%Mettler-Toledo International (NYSE:MTD)Holding Weight: 3.65%Halozyme Therapeutics (NASDAQ:HALO)Holding Weight: 3.60%ACADIA Pharmaceuticals (NASDAQ:ACAD)Holding Weight: 3.55%Full Holdings DetailsFBT Sector ExposureFBT Industry Exposure This page (NYSEARCA:FBT) was last updated on 2/19/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredAmerica cannot power AIThere’s a fatal flaw at the heart of the AI revolution… With AI continuing to explode in popularity, tech c...Porter & Company | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding First Trust NYSE Arca Biotechnology Index Fund Please log in to your account or sign up in order to add this asset to your watchlist. Share First Trust NYSE Arca Biotechnology Index Fund With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.